Related Experiment Videos

p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20

James R Jabbur1, Wei Zhang

  • 1Department of Pathology, Cancer Genomics Laboratory, Graduate Program in Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Cancer Biology & Therapy
|November 15, 2002
PubMed

Insights

Mimicking phosphorylation of p53 at Thr18 and Ser20 with Asp substitution enhanced its tumor suppressor activity. This modification reduced Mdm-2 binding, boosting target gene expression and inhibiting cell proliferation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • p53 phosphorylation at Thr18 and Ser20 is induced by irradiation.
  • Phosphorylation at these sites decreases Mdm-2 binding and enhances p53 target gene transactivation.

Purpose of the Study:

  • To investigate the functional impact of Asp substitution at Thr18 and Ser20 (p53Tl8D/S20D) on p53 regulation.
  • To mimic phosphorylation using Asp substitution to introduce a negative charge.

Main Methods:

  • Investigated p53Tl8D/S20D resistance to calpain digestion.
  • Assessed GST-Mdm-2 binding of p53Tl8D/S20D in vitro.
  • Measured endogenous expression of p53 targets p21(Waf1/Cip1) and fas/APO-1.
  • Compared cell proliferation rates between p53Tl8D/S20D and wild-type p53 transfected cells.

Main Results:

  • p53Tl8D/S20D was resistant to calpain digestion.
  • p53Tl8D/S20D exhibited reduced binding to GST-Mdm-2.
  • Transfected p53Tl8D/S20D enhanced p21(Waf1/Cip1) and fas/APO-1 expression.
  • p53Tl8D/S20D significantly curtailed cell proliferation compared to wild-type p53.

Conclusions:

  • Asp substitution at Thr18 and Ser20 mimics phosphorylation, reducing Mdm-2 interaction.
  • This modification upregulates cell-cycle and apoptotic regulatory targets.
  • p53Tl8D/S20D effectively curtails cellular proliferation, highlighting its role in tumor suppression.

Related Concept Videos